Skip to content

Clinical study of Simiao Sanjie prescription for the treatment of phlegm-dampness-stagnation heat subsolid pulmonary nodules and the construction of microscopic map of "hidden syndrome"

The construction of whole cycle tumor prevention and treatment system based on TCM thinking and the clinical study of the application of Yisimiaosanjie formula in the treatment of phlegm-dampness and heat-suppressing subsolid pulmonary nodules and the construction of microscopic map of "hidden syndrome"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000804
Enrollment
Unknown
Registered
2024-12-12
Start date
2024-04-03
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subsolid pulmonary nodules

Interventions

treatment group:Simiao Sanjie prescription was given oral treatment for 24 weeks

Sponsors

Guanganmen Hospital China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-75 years old; 2)Karnofsky score =90; 3) Consistent with the diagnosis of phlegm-dampness-stagnation heat syndrome; (4) SSN with an average diameter of 5-15mm and stable for >3 months; 5) Meet the diagnostic criteria of SSN: 6) the functions of the heart liver kidney and hematopoietic system are basically normal; 7) Volunteer to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Total number of pulmonary nodules =10; 2) Patients with a history of malignant tumor; 3) Patients who are taking oral antibiotics; (4) Patients with severe cardiovascular cerebrovascular or hematopoietic diseases or diseases of liver kidney and other important organs; (5) Children pregnant women mentally ill or nursing patients; 6) Patients who have received Chinese medicine treatment within 1 month; 7) Patients who are allergic to the Chinese medicine they are taking; Patients who are participating in other clinical studies; 9) Patients with a history of psychotropic drug abuse and unable to abstain patients with intellectual and mental disorders unable to cooperate in evaluation; 10) Patients who are judged by the investigator to be unable to cooperate with the completion of the study or are not suitable for enrollment due to serious hazards to the safety of subjects.

Design outcomes

Secondary

MeasureTime frame
TCM syndrome evaluation, psychological state evaluation;Progression rate and stabilization rate of solid pulmonary nodules treated by Simiao Sanjie formula;

Primary

MeasureTime frame
Effectiveness of Simiao Sanjie prescription in treating subsolid pulmonary nodules;

Countries

China

Contacts

Public Contactliurui

Guanganmen Hospital China Academy of Chinese Medical Sciences

drliur@126.com15210975095

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026